SCNI · Scinai Immunotherapeutics Ltd. · Documents
Market Cap
$921,954
Shares
1.35M
Volume · Oct 21
181.3K
Avg daily vol (43 sessions)
3.17M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2024-08-13 | — | |
| 6-K | — | 2024-08-12 | — | |
| 6-K/A | — | 2024-08-07 | — | |
| 6-K | — | 2024-08-05 | — | |
| 6-K | — | 2024-07-15 | — | |
| 6-K | — | 2024-07-15 | — | |
| 6-K | — | 2024-07-08 | — | |
| 6-K | — | 2024-07-08 | — | |
| 6-K | — | 2024-07-08 | — | |
| 6-K | — | 2024-06-14 | — | |
| 6-K | — | 2024-06-13 | — | |
| 6-K | — | 2024-06-13 | — | |
| 6-K | — | 2024-05-28 | — | |
| 20-F | — | 2024-05-15 | 2023-12-31 | |
| 6-K | — | 2024-05-15 | — | |
| 6-K | — | 2024-05-07 | — | |
| NT 20-F | — | 2024-04-30 | 2023-12-31 | |
| 6-K | — | 2024-04-25 | — | |
| 6-K | — | 2024-04-16 | — | |
| F-3 | — | 2024-01-30 | — | |
| 6-K | — | 2024-01-18 | — | |
| 6-K | — | 2024-01-09 | — | |
| 6-K | — | 2024-01-04 | — | |
| 6-K | — | 2024-01-02 | — | |
| 6-K | — | 2024-01-02 | — | |
| F-1/A | — | 2023-12-22 | — | |
| 6-K | — | 2023-12-14 | — | |
| 6-K | — | 2023-11-20 | — | |
| 6-K | — | 2023-11-13 | — | |
| 6-K | — | 2023-11-07 | — | |
| 6-K | — | 2023-11-03 | — | |
| 6-K | — | 2023-11-02 | — | |
| F-1 | — | 2023-10-30 | — | |
| 6-K | — | 2023-09-22 | — | |
| 6-K | — | 2023-09-20 | — | |
| 6-K | — | 2023-09-19 | — | |
| 6-K | — | 2023-09-11 | — | |
| 6-K | — | 2023-09-06 | — | |
| 6-K | — | 2023-09-06 | — | |
| 6-K | — | 2023-08-24 | — | |
| 6-K | — | 2023-08-23 | — | |
| F-3 | — | 2023-08-18 | — | |
| 6-K/A | — | 2023-08-18 | 2023-06-30 | |
| 6-K/A | — | 2023-08-14 | 2023-06-30 | |
| 6-K | — | 2023-08-11 | — | |
| 6-K | — | 2023-08-01 | — | |
| 6-K | — | 2023-07-12 | — | |
| 6-K | — | 2023-07-05 | — | |
| 6-K | — | 2023-07-05 | — | |
| 6-K | — | 2023-07-03 | — |
Showing 51–100 of 198 filings